These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography? Kulkarni SC; Sundaram PS; Padma S Nucl Med Commun; 2020 Feb; 41(2):139-146. PubMed ID: 31714366 [TBL] [Abstract][Full Text] [Related]
24. Lymph node staging with fluorine-18 prostate specific membrane antigen 1007-positron emission tomography/computed tomography in newly diagnosed intermediate- to high-risk prostate cancer using histopathological evaluation of extended pelvic node dissection as reference. Hermsen R; Wedick EBC; Vinken MJM; van Kalmthout LWM; Küsters-Vandevelde HVN; Wijers CHW; Somford DM; van Basten JA Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3929-3937. PubMed ID: 35543733 [TBL] [Abstract][Full Text] [Related]
25. Establishment and prospective validation of an SUV Jiao J; Kang F; Zhang J; Quan Z; Wen W; Zhao X; Ma S; Wu P; Yang F; Guo W; Yang X; Yuan J; Shi Y; Wang J; Qin W Theranostics; 2021; 11(17):8396-8411. PubMed ID: 34373749 [No Abstract] [Full Text] [Related]
27. Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values. Rogic I; Golubic AT; Zuvic M; Smitran T; Jukic N; Gamulin M; Kastelan Z; Huic D Nucl Med Rev Cent East Eur; 2024; 27(0):6-12. PubMed ID: 38680016 [TBL] [Abstract][Full Text] [Related]
28. Prostate-Specific Membrane Antigen PET/CT Combined with Sentinel Node Biopsy for Primary Lymph Node Staging in Prostate Cancer. Hinsenveld FJ; Wit EMK; van Leeuwen PJ; Brouwer OR; Donswijk ML; Tillier CN; Vegt E; van Muilekom E; van Oosterom MN; van Leeuwen FWB; van der Poel HG J Nucl Med; 2020 Apr; 61(4):540-545. PubMed ID: 31562222 [TBL] [Abstract][Full Text] [Related]
29. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
30. High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation. Rahman LA; Rutagengwa D; Lin P; Lin M; Yap J; Lai K; Mancuso P; Rathore P; Haghighi K; Gassner P; Wong LH; Lalak N Cancer Imaging; 2019 Dec; 19(1):86. PubMed ID: 31829288 [TBL] [Abstract][Full Text] [Related]
31. Comparison of Schollhammer R; Robert G; Asselineau J; Yacoub M; Vimont D; Balamoutoff N; Bladou F; Bénard A; Hindié E; Gallerande HC; Morgat C J Nucl Med; 2023 Mar; 64(3):379-385. PubMed ID: 36215569 [TBL] [Abstract][Full Text] [Related]
32. Impact of uptake time on image quality of [ van der Sar ECA; Viol SLM; Braat AJAT; van Rooij R; Lam MGEH; de Jong HWAM; de Keizer B Med Phys; 2023 Dec; 50(12):7619-7628. PubMed ID: 37093883 [TBL] [Abstract][Full Text] [Related]
33. Potential Impact of Calais J; Kishan AU; Cao M; Fendler WP; Eiber M; Herrmann K; Ceci F; Reiter RE; Rettig MB; Hegde JV; Shaverdian N; King CR; Steinberg ML; Czernin J; Nickols NG J Nucl Med; 2018 Nov; 59(11):1714-1721. PubMed ID: 29653978 [TBL] [Abstract][Full Text] [Related]